Seshadri Neervannan, Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 9,758 shares at $30.60 ($299K) on 2024-03-18, disclosed to the SEC on 2024-03-19.
Open-market sale of $299k TARS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.60 | 4,879 | $149K | 50.0% |
| 2 | $30.60 | 4,879 | $149K | 50.0% |
| Total | $30.60 avg | 9,758 | $299K | 100% |
| Filing → |
| TARS | SELL | 2026-03-19 | $772K | — | Filing → |
| TARS | SELL | 2026-03-05 | $641K | — | Filing → |
| TARS | SELL | 2025-03-20 | $726K | — | Filing → |